Actavis Inc. said it has received U.S. approval to sell a generic version of Lamictal, a tablet for treating epilepsy and bipolar disorder. The FDA has given approval for the company to sell lamotrigine tablets in doses of 25, 50, 100 and 200 milligrams. Read the full story